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Abstract
Objective: Paediatric ovarian germ cell tumours (GCTs) are rare tumours with malignant tumours extremely rare.
Methods: All the paediatric patients who received treatment for histology proven ovarian GCT at Shaukat Khanum 
Memorial Cancer Hospital from January 2006 to December 2014 were retrospectively reviewed. Patients over the 
age of 18 years were excluded from the study. A total of 109 patients were included in the study. A set of parameters 
were identified to record initial clinical presentation and examination, imaging and laboratory investigations including 
tumour marker levels. Decisions of multidisciplinary team meetings, surgical treatment, neo-adjuvant, adjuvant 
chemotherapy and radiation data retrieved. Data analysis carried out using SPSS 20.
Results: In total 109 girls presented to our hospital during the study period, most of them above the age of 
5 years, with dysgerminoma being the most common followed by yolk sac tumour. Most of the patients received 
treatment outside our hospital and were referred here for chemoradiotherapy. Fertility-preserving surgery was the 
most commonly performed surgical procedure with a mean follow-up of 50.4 months and >75% overall 5-year 
survival.
Conclusion: Regardless of histologic types, the outcomes of GCT can be improved with a multidisciplinary approach.
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Introduction
Germ cell tumours (GCTs) are rare tumours based on 
population analysis. In general, 80% of the GCTs are 
benign compared to 20% malignant GCT (constituting 
2–3% of heterogeneous rare malignant paediatric 
tumours).[1] GCTs have a bimodal age distribution with the 
first peak in infant age group and the second peak starts 
in adolescence.[2,3] There is an increase in the incidence 
rate of GCTs in paediatric age group in Australia, Europe, 
and the United States.[4] During the teen years, girls are 
slightly more frequently affected as compared to boys 
with a ratio of 1:0.8.[5]
The ovarian GCT may present clinically with an ovarian 
mass. Signs and symptoms of precocious puberty or 
virilisation as a result of excessive hormone production 
may be present.[6] Common sites of ovarian GCT are 
gonadal, presacral and retroperitoneal. Prognosis is mainly 
dependent on the site and age at diagnosis.[6] The ovarian 
GCTs are mostly diagnosed in the fifth decade of life with 
12% of patients below the age of 30 years,[7] the most 
common are the juvenile granulosa cell tumours, which 
are mostly localized at presentation with an excellent 
prognosis,[8,9] in contrast to that in adults, the adult-type 
granulosa cell tumours are often diagnosed at an advanced 
stage with an increased risk of endometrial cancer due 
to prolonged oestrogen exposure secondary to excessive 
tumour secretion.[10]
In the past, limited focus was given to chemotherapy for 
ovarian GCT, which has got a very clear role now. As there 
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is gradual increase in the incidence of ovarian GCT, data 
from Pakistan regarding the profile of ovarian GCT at 
presentation and management are limited. We conducted 
this study to evaluate the role of chemotherapy in ovarian 
GCT as our current knowledge regarding incidence of 
ovarian GCT in Pakistan is incomplete. We have compiled 
data from our hospital which is a charity cancer hospital 
and referral centre. It is a retrospective study with design 
to gather demographic information, clinical presentation, 
management and survival outcome of ovarian GCT from 
a tertiary care cancer hospital in Pakistan.
Methods
Data of patients who received treatment for histology 
proven ovarian GCT at Shaukat Khanum Cancer Hospital 
from January 2006 to December 2014 were retrospectively 
reviewed. Patients over the age of 18 years and males 
were excluded from the study. Hospital records of all the 
patients with a diagnosis of ovarian GCT were included 
in the study. A set of parameters were identified to record 
initial clinical presentation and examination, imaging and 
laboratory investigations including tumour marker levels. 
Decisions of multidisciplinary team meetings, surgical 
treatment, neoadjuvant, post-operative chemotherapy and 
radiation data retrieved. Patients were stratified on the basis 
of age, clinical stage and type of tumour. Each individual 
ovarian GCT was categorized in terms of diagnosis, 
surgery, chemotherapy and outcome. Overall survival was 
calculated by subtracting date of last follow-up from date 
of the first presentation to hospital. Kaplan–Meier curves 
were used to determine estimated overall survival. All 
analyses were performed on SPSS version 20.
Results
A total of 109 girls presented to our hospital during the 
study period. Majority of the patients were from Punjab 
(70%) followed by Khyber Pakhtunkhwa (25%). Most 
of the patients (72.4%) were above the age of 5 years. 
Gonads (78%) are the most frequently involved site with 
dysgerminoma (41%) being the most common tumour 
followed by yolk sac tumour (38.6%) as shown in Table 1. 
Most of the surgeries were performed outside our hospital 
and were referred to our hospital for chemotherapy and 
completion surgery. However, the scope of this paper is 
to study the surgical treatment in our cohort and does not 
cover the details of chemotherapy regimens.
Seventy-four (68%) patients underwent fertility-
preserving surgery, 13 (12%) patients underwent 
exploratory laparotomy and no surgery was offered to 













<1 year 5 (4.6)
1–5 years 25 (23)
>5 years 79 (72.4)
Histopathology
Dysgerminoma 44 (41.0)
Yolk sac tumour 42 (38.6)
Teratoma 20 (18.1)
Embryonal carcinoma 3 (2.4)
Table 2: Management
Primary surgery Patients (n=109) (%)
Fertility‑preserving surgery 74 (68)




No surgery 11 (10)
Total 109 (100)
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was performed in 11 (10.1%) patients and debulking was 
performed in 4 (3.7%) patients while two were found 
irresectable.
Metastasis was present in 8 (7.3%) patients and recurrence 
was found in 15 (13.8%) patients on long-term follow-up 
as shown in Table 2. Patients had a mean follow-up of 
50.4 months and >75% overall 5-year survival as shown 
in Graph 1.
Discussion
Ovarian GCTs account for 20–25% of all ovarian 
neoplasms and only about 3% of these are malignant. 
GCTs are broadly classified as dysgerminomas and non-
dysgerminomas. This is important because their natural 
history and response to treatment, prognosis and survival 
times are very different. The main finding of our study was 
that the paediatric ovarian GCTs are although rare, and 
very few patients reach specialized centres; the incidence 
increases with increasing age.
In our study, dysgerminomas were the most common 
tumour followed by yolk sac tumour, whereas in a study 
conducted by Billmire et al.[11] primarily carried out 
on children with ovarian GCT, teratoma was the most 
prevalent histology, while other studies also showed 
teratoma being the most common type of paediatric 
ovarian GCT.[12,13] Most of the paediatric ovarian GCTs 
are gonadal (85) in our study as compare to extragonadal 
which was present in 24 patients which is similar to a 
study conducted by Marina et al., showing more gonadal 
involvement than extragonadal.[14]
The overall outcome for our patients was fairly good, 
as almost 75% of the patients were alive at 5-year 
follow-up [Graph 1]. A report by the Children’s 
Oncology Group from the USA showed that almost half 
of the patients diagnosed with Stage I malignant ovarian 
GCT had recurrent or persistent disease without the 
chemotherapy, but with chemotherapy, the overall survival 
was found to be around 95%.[15]
There are few limitations to our study. First, it was a 
retrospective study. Second, most of the patients were 
operated outside our hospital and were referred here for 
further treatment. Data on chemotherapy were difficult to 
get with the lack of infrastructure. Third, chemotherapy 
regimen data are inadequate to comment on survival 
of this study population. Finally, there was little pre-
operative information available, including clinical and 
tumour marker levels posing diagnostic and management 
challenges in few cases. Here, we present gathered data 
from all patients who presented to our hospital during the 
study period and were analysed to give our local data. 
Further prospective studies with detailed information 
about pre-operative staging workup, chemotherapy 
regimen and post-surgical course should be undertaken.
Conclusion
Paediatric ovarian GCTs are curable tumours with good 
prognosis, survival can be improved by early diagnosis 
of proper treatment and follow-up. Awareness regarding 
general management principals of GCT in Pakistan needs 
to be much improved.
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